Alta Partners VIII, L.P.

All filings by Alta Partners VIII, L.P. on record concern Sutro Biopharma, Inc. The record holds 4 filings, all for trades on 1 October 2018.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 1 October 2018 with a transaction in Sutro Biopharma, Inc. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.